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Significance and Impact of the Study: This study presents the isolation of a Streptomyces strain, named
WAB9, from a Saharan soil in Algeria. This strain was found to produce a new hydroxamic acid-contain-
ing molecule with interesting antimicrobial activities towards various multidrug-resistant micro-organ-
isms. Although hydroxamic acid-containing molecules are known to exhibit low toxicities in general,
only real evaluations of the toxicity levels could decide on the applications for which this new molecule
is potentially most appropriate. Thus, this article provides a new framework of research.
Abstract
During screening for potentially antimicrobial actinobacteria, a highly
antagonistic strain, designated WAB9, was isolated from a Saharan soil of
Algeria. A polyphasic approach characterized the strain taxonomically as a
member of the genus Streptomyces. The strain WAB9 exhibited a broad
spectrum of antimicrobial activity toward various multidrug-resistant micro-
organisms. A PCR-based assay of genomic potential for producing bioactive
metabolites revealed the presence of PKS-II gene. After 6 days of strain
fermentation, one bioactive compound was extracted from the remaining
aqueous phase and then purified by HPLC. The chemical structure of the
compound was determined by spectroscopic (UV–visible, and 1H and 13C
NMR) and spectrometric analysis. The compound was identified to be
2-amino-N-(2-amino-3-phenylpropanoyl)-N-hydroxy-3-phenylpropanamide, a
novel hydroxamic acid-containing molecule. The pure molecule showed
appreciable minimum inhibitory concentration values against a selection of
drug-resistant bacteria, filamentous fungi and yeasts.
Keywords
antimicrobial activity, hydroxamic acid, 
Streptomyces, structure elucidation, 
taxonomy.
Correspondence
Nasserdine Sabaou, Laboratoire de Biologie 
des Systemes Microbiens, Ecole Normale 
Superieure de Kouba, Alger 16050, Algeria. 
E-mail: sabaou@yahoo.fr
doi:10.1111/lam.12412
Introduction
Actinobacteria are a group of ubiquitous Gram-positive
bacteria with a percentage of guanine–cytosine higher
than 55%, and most of them produce mycelia. Because of
their ability to provide a broad range of bioactive com-
pounds, these micro-organisms have attracted much
interest. Members of this group, in particular those
belonging to the genus Streptomyces, are considered as the
most important producers of bioactive molecules. There-
fore, Streptomyces have been thoroughly investigated with
respect to their effects against pathogenic strains and have
led to the discovery of a large number of novel active
compounds of considerable value (Solecka et al. 2012).
However, the present context of both a decline in the dis-
covery of new antibiotics and an increase in drug-resis-
tant pathogens makes the screening for new antibiotic-
producing Streptomyces essential.
One of the strategies for enhancing the likelihood of
obtaining particularly interesting isolates and secondary
metabolites is to analyse extreme habitats (Santhanam
et al. 2012), such as arid Saharan soils. Previous surveys
the targeted bacteria, filamentous fungi and yeasts (dis-
tance of inhibition ranged between 15 and 35 mm). Sal-
monella enterica and Candida albicans were the least
sensitive (distance of inhibition <20 mm). The use of
antibiotics as selective agents in the isolation of actino-
bacteria has already been mentioned as a successful
method for the isolation of interesting strains originating
Table 1 Antagonistic properties of the strain WAB9 against various
multidrug-resistant micro-organisms
Target micro-organism
(antibiotic resistance pattern*) Activity† (mm)
Bacillus subtilis ATCC 6633 (NEO) 39
Staphylococcus aureus S1
(CAR, GEN, K, NEO, OLE, SPI, VAN)
28
Enterobacter cloacae E13 (AMC, ATM, CEP,
CTX, FEP, FOX, GEN, PIP, TCC, TIC, TOB)
29
Escherichia coli E52 (ATM, CAZ, CEP, CTX,
FEP, GEN, PIP, TIC, TOB)
35
Klebsiella pneumoniae K44 (AMX, AN, CF,
CRO, CTX, CXM, GEN, K, MZ, SSS, TIC)
29
Pseudomonas aeruginosa IPA1 (AMX, CAR,
GEN, NEO, SPI, SSS, VAN)
29
Salmonella enterica E32 (ATM, CAZ, CEP,
CTX, FEP, GEM, PIP, TIC, TOB)
16
Fusarium culmorum (CHX, ITR, NYS, TIZ) 39
Fusarium moniliforme (AMB, CHX, NYS, TIZ) 29
Fusarium sporotrichoides
(AMB, CHX, ITR, NYS, TIZ, TER)
20
Fusarium graminearum (CHX, NYS, TIZ) 25
Fusarium oxysporum f. sp. lini (ITR,TIZ) 25
F. oxysporum f. sp. albedinis
(AMB, CHX, ITR, NYS, TIZ, TER)
26
Fusarium proliferatum (CHX, ITR, NYS, TIZ) 22
Fusarium equiseti (CHX, TIZ) 30
Aspergillus carbonarius (CHX, NYS) 33
Aspergillus niger (AMB, CHX, NYS, TIZ) 25
Aspergillus flavus (TIZ) 26
Aspergillus parasiticus (AMB, CHX, ITR, NYS, TIZ) 20
Penicillium glabrum (CHX) 38
Penicillium expansum 37
Umbelopsis ramanniana (CHX, ITR, TIZ, TER) 36
Candida albicans IPA 200 (NYS, ITR, TIZ, CHX, TER) 15
Saccharomyces cerevisiae ATCC 4226 34
AMC, amoxicillin + clavulanic acid; AMX, amoxicillin; AN, amikacin;
ATM, aztreonam; C, chloramphenicol; CAR, carbenicillin; CAZ, ceftazi-
dime; CFP, cefpirome; CRO, ceftriaxone; CTX, cefotaxime; CXM, ce-
furoxime; FEP, cefepime; FOX, cefoxitin; GEN, gentamicin; K,
kanamycin; MZ, mezlocillin; NEO, neomycin; OLE, oleandomycin PIP,
piperacillin; SPI; spiramycin; SSS, sulfamide; TCC, ticarcillin + clavulan-
ic acid; TIC, ticarcillin; TOB, tobramycin; VAN, vancomycin; AMB,
amphotericin B; CHX, cycloheximide; ITR, itraconazole; NYS, nystatin;
TIZ, thioconazole; TER, terbinafine.
*The antibiotic resistance patterns were evaluated in house as
described by Touati et al. (2006).
†Activity estimated by measuring the length of inhibition between
Actinomycetes and target micro-organisms.
on the ecological distribution of Actinomycetes in Alge-
rian Saharan soils have already demonstrated their appre-
ciable biodiversity (Sabaou et al. 1998) and permitted 
new species and new antibiotics to be found (Boubetra 
et al. 2013; Meklat et al. 2013).
Hydroxamic acids (bearing the functional group N-
hydroxy amide) are one such interesting class of molecule 
produced by many Streptomyces species (Dimkpa et al. 
2008; Kodani et al. 2013). Their low toxicities in general, 
their weak acid properties and their ability for complex-
ing transition metal ions have resulted in these molecules 
receiving considerable attention for broad therapeutic and 
industrial applications (Vanjari and Pande 2003; Rho 
et al. 2006; Jahangirian et al. 2011). Among their numer-
ous properties, hydroxamic acids and derivatives have 
been largely reported as effective antibacterial and anti-
fungal agents (Li et al. 2003; Pepeljnjak et al. 2005). These 
activities are connected with the ability of hydroxamic 
acids to potently and selectively inhibit a range of 
enzymes that are vital for the survival of bacteria, such as 
various metalloproteinases, urease, cyclooxygenases and 
peroxidase (Muri et al. 2004).
Recently, exploration of microbial antibiotic potential 
has focused on the screening of polyketide synthase (PKS) 
and nonribosomal peptide synthetase (NRPS) genes. This 
exploration approach seems applicable for hydroxamic 
acid-containing molecules, since these molecules are 
already known to be synthesized through NRPS-depen-
dent or independent pathways (Barry and Challis 2009; 
Oves-Costales et al. 2009).
Here, we describe the isolation of a highly antagonistic 
Streptomyces strain, designated WAB9, from a Saharan soil 
sample and its identification by conventional and molecu-
lar methods, together with production and structure eluci-
dation of the corresponding bioactive compound, which 
was found to be a new hydroxamic acid-containing antibi-
otic. The minimum inhibitory concentrations (MICs) of 
this antibiotic were also evaluated on a set of various mul-
tidrug-resistant bacteria, filamentous fungi and yeasts.
Results and discussion
The strain WAB9 was isolated by plating a 2 : 10 serial 
dilution of the soil sample of Bechar on chitin-vitamin 
agar medium supplemented with selective antibiotics. 
This strain was found in only a single small colony, which 
shows it rarity.
Antagonistic properties and detection of PKS and NRPS 
sequences
The strain WAB9 exhibited a broad spectrum of antimi-
crobial activity (Table 1), since it was active against all
mannitol, rhamnose, salicine, xylose, histidine, phenylala-
nine, proline, starch and xanthine, but not melibiose, raf-
finose or sucrose. The strain was able to grow in the
presence of phenol (01% w/v), penicillin (10 UI) and rif-
ampicin (50 lg ml1), but not at 45°C or in the presence
of sodium azide (001% w/v) or NaCl (10% w/v). Fur-
thermore, strain WAB9 could not reduce nitrate.
The 16S rRNA gene sequence (1378 bp) of the strain
was determined and deposited in the GenBank data
library under the accession number KF313072. The
sequence was aligned with those of Streptomyces reference
species available in the GenBank database, which con-
firmed the identification of the strain at the genus level.
The phylogenic relationship between strain WAB9 and
the other Streptomyces species can be seen in the neigh-
bour-joining dendrogram (Fig. 1). The similarity level
was 9985% with Streptomyces ambofaciens ATCC 23877T
(K€ampfer 2012), the most closely related species. Pheno-
typically, the strain WAB9 was found to resemble S. am-
bofaciens except for the resistance to penicillin (10 UI),
which is absent in S. ambofaciens. Furthermore, the strain
WAB9 exhibited both antibacterial and antifungal activi-
ties, while S. ambofaciens was only known to produce
antibacterial antibiotics, namely spiramycin and netropsin
(Pang et al. 2004).
Detection and purification of the bioactive compound
The aqueous phase remaining after n-butanol extraction
of the culture filtrate (resulting from 6-day-old fermenta-
tion) was found to provide the optimal conditions for
both production and extraction (Fig. S1). The HPLC
Strain WAB9 (KF313072)
Streptomyces ambofaciens  ATCC 23877T (M27245)
Streptomyces heliomycini NBRC 15899T (AB184712)
Streptomyces griseoflavus LMG 19344T (AJ781322)
Streptomyces collinus NBRC 12759T (AB184123) 
Streptomyces violaceochromogenes NBRC 13100T (AB184312) 
Streptomyces flaveolus NBRC 3715T  (AB184786)
Streptomyces viridochromogenes NBRC 3113T  (AB184728)
Streptomyces paradoxus NBRC 14887T (AB184628) 
Streptomyces tritolerans DSM 41899T (DQ345779)
91
50
99
57
0·001
Figure 1 Neighbour-joining tree (Saitou and Nei 1987) based on 16S rDNA sequences showing the relationship between strain WAB9 and the
other Streptomyces species. The numbers at the nodes indicate the levels of bootstrap support based on Neighbour-joining analyses of 1000
re-sampled data sets. Bar, 0001 nt substitution per nt position. Streptomyces tritolerans DSM 41899T has been used as outgroup.
from Saharan soils (Sabaou et al. 1998) and has permitted 
novel species and antibiotics to be discovered (Boubetra 
et al. 2013; Meklat et al. 2013).
Only the PKS-II gene was detected through the PCR-
based screening of genomic potential for producing bio-
active metabolites (data not shown). This result suggests 
the possible involvement of a pathway mediated by PKS 
for the production of the antibiotic related to the activity 
expressed by the strain WAB9. Nevertheless, the implica-
tion of other genes in the biosynthesis of the bioactive 
product cannot be excluded since the absence of PKS and 
NRPS amplification products from some active actinobac-
terial strains has already been observed (Meklat et al. 
2012).
Taxonomy of the strain WAB9
The strain grew well on all media. It formed nonfrag-
mented, colourless substrate mycelium. The aerial myce-
lium was greenish grey and produced numerous spiralled 
chains of nonmobile spores on sporophores. Diffusible 
pigments were not observed. The strain contained LL-dia-
minopimelic acid isomer and glycine in the cell wall. The 
whole-cell hydrolysates contained galactose and glucose. 
This indicates that the strain WAB9 has cell wall chemo-
type IC (Lechevalier and Lechevalier 1970). The phospho-
lipid pattern was type PII (Lechevalier et al. 1977) 
characterized by the presence of phosphatidylethanol-
amine. Based on the morphological and chemical charac-
terization, the strain WAB9 was classified as a member of 
the genus Streptomyces (Holt et al. 1994). Physiologically, 
the strain utilized arabinose, fructose, galactose, inositol,
not observed due to rapid exchange with MeOD. The 2D
1H-1H and 1H-13C experiments and especially the long
range 1H-13C couplings observed in the HMBC spectrum
(Fig. 2B) established the connectivity between all the
groups of the molecule. The structure of the compound
W9 was determined by NMR and mass spectrometry to
be 2-amino-N-(2-amino-3-phenylpropanoyl)-N-hydroxy-
3-phenylpropanamide, which thus corresponded to a hy-
droxamic acid-containing molecule with two phenylala-
nine residues. No resemblance was noted when the
structure of compound W9 was compared with structures
reported in the literature, notably in the www.sciencefind-
er.com and www.chemspider.com databases, or antibiotics
described in The Dictionary of Natural Products (Buck-
ingham 1997), or in Berdy’s review of bioactive microbial
metabolites (Berdy 2005).
Numerous Streptomyces species have been reported to
produce active acid-containing molecules (Dimkpa et al.
2008; Kodani et al. 2013). For example, alahopcin and ac-
tinonin are well-known antibiotic agents functionalized
by hydroxamic acids, both of which were first isolated
from a culture of Streptomyces sp. and showed a broad
antimicrobial spectrum, especially against some previously
antibiotic-resistant types of micro-organisms such as
Staphylococcus aureus (Gordon et al. 1962; Higashide
et al. 1985).
Furthermore, hydroxamic acids are also used for their
metal-chelating properties. Desferrioxamine, which was
first isolated from a Streptomyces species by Yang and
Leong (1982), is routinely used for treating iron intoxica-
tion and overload in human patients (Franchini and Ve-
neri 2004) and metal-chelating hydroxamic acids, such as
those produced by Streptomyces acidiscabies E13, can be
effective bioremediators in heavy-metal contaminated
fields (Dimkpa et al. 2008).
Given their significant ability to scavenge reactive oxy-
gen species, hydroxamic acids have also drawn much
attention in oncology and food safety as protective agents
against free radical-mediated disorders (Taira et al. 2002;
Garcia-Manero et al. 2008).
Minimum inhibitory concentrations
As summarized in Table 3, the pure bioactive compound
exhibited appreciable MIC values towards a broad range
of the multidrug-resistant pathogens tested, including
Gram-positive bacteria, Gram-negative bacteria, filamen-
tous fungi and yeasts. Among these micro-organisms, the
most sensitive were Pseudomonas aeruginosa IPA1
(10 lg ml1), Escherichia coli E52 (20 lg ml1) and all of
the targeted Fusarium species (8–40 lg ml1). The strains
of Aspergillus and Penicillium and the yeast C. albicans
IPA 200 were the most resistant (40–80 ml1).
1H and 13C number*
1H chemical
shift (ppm)
13C chemical
shift (ppm)
1-10 – 17429
2-11 368 5593
3-12 292–298 3645
4-13 – 13480
5-9-14-18 703 12910
6-8-15-17 713 12884
7-16 708 12741
*See Fig. 2 for numbering of hydrogen and carbon atoms.
NH2
N
O
OH
O
NH2
NH2
N
O
OH
O
NH2
1
2
3
4
16
5
6
7
8
9
10
11
12
13
14
15
17
18
(a)
(b)
Figure 2 Structure of the bioactive compound (a) and HMBC and
COSY correlations (b). ( ) 1H-13C HMBC correlation and ( ) 1H-
1H COSY correlation.
profile of this phase showed one active peak (named W9) 
at a retention time of 2502 min and UV detection at 
220 nm. The final purification was achieved after the sec-
ond re-injection in the HPLC system (Fig. S2).
Elucidation of the structure of the active compound
The UV–visible spectrum of the active compound W9 
exhibited maximum absorptions at 257 and 265 nm, 
which putatively indicated the presence of unsaturated 
aromatic complexes. The ESI-MS spectrum contained an 
ion peak at m/z 3260 [M-H] (Fig. S3). Thus, the molec-
ular weight of this compound was M = 327.
The 1H and 13C NMR chemical shifts of the compound 
are given in Table 2 and the structure in Fig. 2. The 13C, 
HSQC and HMBC spectra show seven carbon signals for 
the W9 molecule. It was possible to discern one amide 
group (dc 17429), four sp2–hybridized carbons (dc from 
12741 to 13480) and two sp3-hybridized carbons (dc 
3645–5593). The hydrogens of the hydroxyl group were
Table 2 1H and 13C NMR data assignments of WAB9 compound in 
CD3OD at 298 K
The broad antibacterial and antifungal capacities of hy-
droxamic acids have been extensively reported (Li et al.
2003; Pepeljnjak et al. 2005) and are attributed to their
potent and selective inhibition of a range of enzymes.
These include zinc, nickel and iron metalloproteases, ur-
eases, cyclooxygenases and peptide deformylases (Muri
et al. 2004). Such is the case of actinonin, which is
regarded as a potential inhibitor of peptide deformylases
(Chen et al. 2000).
However, the mode of action at the molecular level is
still not well understood and has been speculated to be due
to the electrophilic character of the hydroxamic moiety. In
this hypothesis, the electrophilicity allows the molecule to
react with nucleophilic centres present in the enzymes
involved in fundamental processes (Bravo and Lazo 1996).
In conclusion, from the results presented in this paper,
we found that the strain Streptomyces sp. WAB 9 pro-
duced a new, small, hydroxamic acid-containing mole-
cule, displaying a broad antimicrobial spectrum with
interesting activities against multidrug-resistant bacteria,
filamentous fungi and yeasts. Regarding the nature and
activity of the molecule, numerous possible therapeutic
(human, veterinary) and nontherapeutic (food processing,
waste management, biofungicide, etc.) applications could
be considered. However, only in vivo evaluation studies
could really prove the effectiveness of the compound in
the applications in question.
Materials and methods
The Actinomycete strain, designated WAB9, was isolated
in our laboratory by the dilution agar plating method,
from a Saharan soil collected in Bechar (31°340N; 2°160W).
Briefly, 1 g of the soil sample was aseptically added to 9 ml
sterile distilled water. The suspension was vortexed and
subjected to a 10-fold serial dilution. Aliquots (02 ml) of
each dilution were spread on the surface of chitin-vitamin
agar medium (Hayakawa and Nonomura 1987) supple-
mented with cycloheximide (50 mg l1) and rifampicin
(10 mg l1). The plates were incubated at 30°C for
2 weeks and then observed by light microscopy. After iso-
lation, the strain WAB9 was purified and maintained at
4°C on slants ISP-2 medium (Shirling and Gottlieb 1966).
Antagonistic properties and detection of PKS and NRPS
sequences
The antagonistic properties of the strain WAB9 against
several bacteria, filamentous fungi and yeasts (listed in
Table 1) were determined by the streak method as
described previously by Boubetra et al. (2013). The anti-
biotic resistance patterns of the target micro-organisms
were evaluated in house according to the method
described by Touati et al. (2006).
The genomic potential for producing bioactive metabo-
lites of the isolate was assessed. Polyketide synthase I and
II (PKS-I, PKS-II) and NRPS genes were amplified from
genomic DNA with the method cited by Meklat et al.
(2012).
Phenotypic, chemical and phylogenetic characterization
The strain WAB9 was identified at the genus level on the
basis of both phenotypic and chemical features according
to criteria described by K€ampfer (2012). The morphologi-
cal characteristics of the strain were studied on Interna-
tional Streptomyces Project (ISP) medium 2, ISP medium
3, ISP medium 4 and ISP medium 5 at 30°C for 14 days.
Twenty-three physiological tests were used to character-
ize the strain. Degradation of different organic substrates
and resistance to several chemical and physical agents
were determined as described by Locci (1989).
For the chemical study of cell constituents, analyses of
diaminopimelic acid and whole-cell sugars were carried out
using the methods of Becker et al. (1964), and Lechevalier
and Lechevalier (1970). Phospholipids were analysed
according to the procedure developed by Minnikin et al.
(1977).
For phylogenetic analysis, genomic DNA of the strain
was extracted for 16S rRNA gene analysis according to
the method of Liu et al. (2000). The 16S rRNA gene was
PCR amplified using the forward FC27 (50-AGAGTTT
GATCCTGGCTCAG-30) and reverse RC1492 (50-GGTTA
CCTTGTTACGACTT-30) primers. Phylogenetic analysis
was performed as described by Meklat et al. (2013).
Target micro-organisms MICs (lg ml1)*
Bacillus subtilis ATCC 6633 10
Pseudomonas aeruginosa IPA1 10
Escherichia coli E52 20
Staphylococcus aureus S1 50
Saccharomyces cerevisiae ATCC 4226 20
Candida albicans IPA 200 60
Fusarium proliferatum 08
Fusarium oxysporum f. sp. lini 15
Fusarium culmorum 25
Fusarium graminearum 30
Fusarium equiseti 40
Umbelopsis ramanniana 20
Aspergillus flavus 40
Aspergillus ochraceus 50
Aspergillus carbonarius 80
Penicillium glabrum 50
*MIC values represent the mean of two replicates.
Table 3 Minimum inhibitory concentrations (MICs) of the antimicro-
bial compound produced by the strain WAB9 against several target 
micro-organisms
013C signals were assigned on the basis of chemical shifts,
spin–spin coupling constants, splitting patterns and signal
intensities, and using 1H-1H COSY45, 1H-13C HSQC and
1H-13C HMBC experiments. Gradient-enhanced 1H
COSY45 was performed and included 36 scans per incre-
ment. 1H-13C correlation spectra using a gradient-
enhanced HSQC sequence (delay optimized for 1JCH of
145 Hz) was obtained with 200 scans per increment. A gra-
dient-enhanced HMBC experiment was performed allow-
ing 625 ms for long-range coupling evolution (340 scans
were accumulated). Typically, 2048 t2 data points were col-
lected for 256 t1 increments.
Determination of MICs
MICs of pure bioactive compound were investigated
using the conventional agar dilution method of Oki et al.
(1990) toward a selection of 16 target micro-organisms.
These micro-organisms were inoculated onto nutrient
agar medium containing different concentrations of active
compounds (1, 2, 3, 5, 8, 10, 15, 20, 25, 30, 40, 50, 60, 80
and 100 mg ml1). After a growth period of 24–48 h at
37°C for bacteria and 48–72 h at 28°C for fungi, the
plates were examined for growth and the lowest antibiotic
concentration that inhibited the growth of each micro-
organism was determined. Medium without active com-
pound and inoculated with target micro-organisms was
used as control.
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Production, isolation and purification of the active 
compound
The fermentations were carried out in ISP-2 broth. This 
medium was chosen among several others because of its 
very good results in our preliminary work. A seed culture 
of strain WAB9 was prepared with the same medium and 
used to inoculate 500-ml Erlenmeyer flasks, each contain-
ing 100 ml of medium. The cultures were incubated on a 
rotary shaker (250 rev min1) at 3  °C. The extraction of 
the active compound was carried out on the day of fer-
mentation exhibiting the optimal production (concomi-
tantly determined by a kinetic assay) after centrifugation 
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Figure S1. Determination of the optimal conditions for
production and extraction of antibiotic W9.
Figure S2. HPLC purification process for the antibiotic
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Figure S3. Nanospray ion electron-spray ionization–
mass spectrum of the antibiotic W9 in negative mode.
